| A brief review of the effects of vitamin D on multiple sclerosis A Miclea, M Bagnoud, A Chan, R Hoepner Frontiers in immunology 11, 781, 2020 | 67 | 2020 |
| Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study A Miclea, VI Leussink, HP Hartung, R Gold, R Hoepner Journal of neurology 263, 1626-1632, 2016 | 45 | 2016 |
| Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course G Zoehner, A Miclea, A Salmen, N Kamber, L Diem, C Friedli, M Bagnoud, ... Therapeutic advances in neurological disorders 12, 1756286419878340, 2019 | 36 | 2019 |
| Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity A Miclea, M Miclea, M Pistor, A Hoepner, A Chan, R Hoepner Brain and behavior 7 (8), e00761, 2017 | 29 | 2017 |
| Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study A Miclea, A Salmen, G Zoehner, L Diem, CP Kamm, ... CNS neuroscience & therapeutics 25 (4), 527-531, 2019 | 28 | 2019 |
| Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age M Briner, M Bagnoud, A Miclea, C Friedli, L Diem, A Chan, R Hoepner, ... Therapeutic advances in neurological disorders 12, 1756286419843450, 2019 | 24 | 2019 |
| Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod ME Evangelopoulos, A Miclea, L Schrewe, M Briner, A Salmen, ... CNS neuroscience & therapeutics 24 (10), 984, 2018 | 22 | 2018 |
| Visual outcomes of plasma exchange treatment of steroid-refractory optic neuritis: a retrospective monocentric analysis N Skorupka, A Miclea, KA Jalowiec, C Bocksrucker, N Kamber, A Chan, ... Transfusion Medicine and Hemotherapy 46 (6), 417-422, 2019 | 11 | 2019 |
| Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort K Veselaj, N Kamber, M Briner, C Friedli, L Diem, K Guse, A Miclea, ... CNS neuroscience & therapeutics 27 (4), 426-438, 2021 | 7 | 2021 |
| Intramuscular testosterone supplementation ameliorates depression in hypogonadal men: a retrospective study in an outpatient department A Miclea, M Miclea, M Pistor, K Stegmayer, R Hoepner Pharmacopsychiatry 51 (06), 257-262, 2018 | 6 | 2018 |
| 1, 25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL) M Pistor, L Schrewe, S Haupeltshofer, A Miclea, S Faissner, A Chan, ... Leukemia research reports 9, 38-41, 2018 | 6 | 2018 |
| Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study L Diem, A Daponte, O Findling, A Miclea, M Briner, A Salmen, R Gold, ... Neurology: Neuroimmunology & Neuroinflammation 7 (2), e660, 2020 | 4 | 2020 |
| Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study A Miclea, A Salmen, R Wiest, G Zoehner, F Wagner, A Hoepner, ... Therapeutic advances in neurological disorders 12, 1756286419835652, 2019 | 4 | 2019 |
| Immunoglobulin levels may aid in the prediction of treatment response in anti-CD20 treatment of multiple sclerosis R Hoepner, A Miclea, J Popovic, N Kamber, A Chan, A Salmen Clinical and Translational Neuroscience 2 (1), 2514183X18764792, 2018 | 2 | 2018 |
| Time to 1st relapse in MS patients treated with dimethyl fumarate or fingolimod: a retrospective European study L Diem, A Daponte, O Findling, R Gold, A Miclea, M Briner, A Salmen, ... MULTIPLE SCLEROSIS JOURNAL 25, 304-304, 2019 | | 2019 |
| Multiple sclerosis disease course and immunotherapy are associated with the prevalence of immunoglobulin deficiency G Zoehner, A Miclea, A Salmen, N Kamber, L Diem, C Friedli, M Bagnoud, ... MULTIPLE SCLEROSIS JOURNAL 25, 167-168, 2019 | | 2019 |
| Immunoglobulin deficiency in multiple sclerosis-prevalence and association with disease-modifying therapy and disease course G Zoehner, A Miclea, A Salmen, N Kamber, L Diem, C Friedli, M Bagnoud, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 341-341, 2019 | | 2019 |
| Head-to-head comparison of clinical efficacy of dimethyl fumarate versus fingolimod in different pretreatment situations: A retrospective European real-world study L Diem, A Daponte, O Findling, R Gold, A Miclea, M Briner, A Salmen, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 487-487, 2019 | | 2019 |
| MOG-IgG antibodies in autoimmune demyelinating CNS disorders-retrospective analysis of a monocentric patient cohort K Veselaj, M Briner, C Friedli, LF Diem, K Guse, A Miclea, R Hoepner, ... MULTIPLE SCLEROSIS JOURNAL 24, 540-541, 2018 | | 2018 |
| Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome A Miclea, A Salmen, R Wiest, F Wagner, A Hoepner, L Schrewe, ... MULTIPLE SCLEROSIS JOURNAL 24, 530-530, 2018 | | 2018 |
